Product
Development

Voyageur is continuously advancing its product development roadmap, building toward a fully integrated contrast media supply chain. Each milestone strengthens the company’s vertical advantage, reducing reliance on external suppliers and positioning Voyageur to meet growing market demand.

Current R&D

VGAS

Voyageur is actively developing V-Gas Effervescent Granules (4g), an innovative antacid and antiflatulent solution poised to alleviate common digestive discomforts while also serving as an integral component in double contrast studies. 

IoXh

Voyageur is rapidly moving towards iodine contrast media production, becoming the first North American iodine contrast media manufacturer1. The company’s first iodine product, IoXh, is actively in development.

Iodine Prill

Iodine prill production forms the foundation of Voyageur’s contrast media strategy. The company is actively progressing this capability as part of an exclusive offtake agreement with Bayer.

Interested in learning more?

Connect with a member of our team to learn more about current and future contrast media products.

Order Now

1 Several companies manufacture finished iodinated contrast media products in the United States through fill-and-finish operations. These companies import the active pharmaceutical ingredients rather than synthesizing them domestically. At present, there is no commercial-scale manufacturing in the U.S. that starts from iodine flake and produces the iodinated contrast APIs.